Fingolimod - Generic Drug Details
✉ Email this page to a colleague
Summary for fingolimod
International Patents: | 137 |
US Patents: | 3 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 20 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Clinical Trials: | 52 |
Patent Applications: | 2,547 |
Drug Prices: | Drug price trends for fingolimod |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for fingolimod |
What excipients (inactive ingredients) are in fingolimod? | fingolimod excipients list |
DailyMed Link: | fingolimod at DailyMed |
Recent Clinical Trials for fingolimod
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tang-Du Hospital | Phase 1/Phase 2 |
The Methodist Hospital Research Institute | Phase 2 |
General Hospital of Shenyang Military Region | Phase 4 |
Generic filers with tentative approvals for FINGOLIMOD
Applicant | Application No. | Strength | Dosage Form |
⤷ Try for Free | ⤷ Try for Free | EQ 0.5MG BASE | CAPSULE;ORAL |
⤷ Try for Free | ⤷ Try for Free | EQ 0.5MG BASE | CAPSULE;ORAL |
⤷ Try for Free | ⤷ Try for Free | 0.5MG | CAPSULE;ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.